Talk AI for Clinical Trials · Data
Evaluating Generative AI in Regulated Environments: A Statistical Rigorous Framework for Regulatory Compliance and Safety
Thu, Feb 6, 2025 · 10:10–10:40 AM EST Rosen Shingle Creek
About this session
The need for rigorous statistical evaluation of generative AI in clinical trial settings is paramount to ensure regulatory compliance and patient safety. This talk explores a framework for assessing whether AI-generated contents, produced by large language models like GPT-4, are non-inferior to human-generated contents across key dimensions such as accuracy, clarity, consistency, and reasoning. The insights gained from this evaluation will be crucial in shaping the future integration of generative AI in regulated environments, potentially transforming how we approach clinical trials and drug development.